Press-release for stocks in the health technology sector

Prices are updated after-hours

sector : Health technology crawled date : 2021 - 09 - 20

save search

Amgen Wins Patent Case on Otezla® (apremilast)
Published: 2021-09-20 (Crawled : 23:00) - prnewswire.com
BGNE | $139.22 6.32% 5.95% 200K

Health Technology

| -65.12% | O: 0.36% H: 1.3% C: -2.86%
patent

Selecta Biosciences Announces Appointment of Kevin Tan as Chief Financial Officer
Published: 2021-09-20 (Crawled : 23:00) - biospace.com/
SELB 4 | $0.8812 -8.0% 2.12% 0

Health Technology

| -79.99% | O: -4.83% H: 0.0% C: 0.0%
bioscience

Phathom Pharmaceuticals Secures $200 Million Term Loan Facility from Hercules Capital
Published: 2021-09-20 (Crawled : 23:00) - biospace.com/
HTGC 4 | $18.85 0.86% 0.26% 900K

Finance

| 12.34% | O: -1.37% H: 1.03% C: -0.3%
PHAT | $9.05 0.44% 0.44% 580K

Health Technology

| -73.08% | O: -2.41% H: 2.53% C: 0.03%

Pacific Biosciences Closes Acquisition of Omniome and Establishes San Diego Presence
Published: 2021-09-20 (Crawled : 23:00) - biospace.com/
PACB | $1.465 -6.09% -6.48% 9.7M

Health Technology

| -95.01% | O: -5.16% H: 2.47% C: 0.25%
acquisition bioscience

Zai Labs to Increase US Presence with New Location in Cambridge
Published: 2021-09-20 (Crawled : 23:00) - biospace.com/
ZLAB | $15.13 0.93% 0.93% 470K

Health Technology

| -88.25% | O: -3.05% H: 1.0% C: -0.54%

Verrica Pharmaceuticals Receives Complete Response Letter from the FDA identifying deficiencies at a facility of a Contract Manufacturer for its New Drug Application for VP-102 for the Treatment of Molluscum Contagiosum
Published: 2021-09-20 (Crawled : 22:00) - biospace.com/
VRCA | $6.85 0.88% 0.88% 86K

Health Technology

| -43.71% | O: -1.15% H: 3.08% C: 0.0%
molluscum new drug treatment fda contract drug

Xencor to Present at the 2021 Cantor Virtual Global Healthcare Conference
Published: 2021-09-20 (Crawled : 22:00) - biospace.com/
XNCR | $18.35 0.77% 0.76% 480K

Health Technology

| -46.86% | O: -1.94% H: 2.15% C: -0.24%
conference

ANI Pharmaceuticals to Present at Cantor Virtual Global Healthcare Conference 2021
Published: 2021-09-20 (Crawled : 22:00) - biospace.com/
ANIP S | $66.13 0.78% 0.77% 86K

Health Technology

| 131.66% | O: -0.67% H: 3.98% C: 3.31%
conference

Seagen to Host Conference Call and Webcast Discussion on September 21, 2021 to Discuss TIVDAK™ (tisotumab vedotin-tftv) Approval
Published: 2021-09-20 (Crawled : 22:00) - biospace.com/
SGEN | $228.74 0.1% 20M

Health Technology

| 48.05% | O: 0.21% H: 3.45% C: 2.74%
approval conference

aTyr Pharma Announces Closing of $86.3 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Published: 2021-09-20 (Crawled : 22:00) - biospace.com/
LIFE | $1.62 -1.22% -1.23% 220K

Health Technology

| -84.29% | O: -3.98% H: 7.58% C: 3.23%
offering pharma

Co-Diagnostics, Inc. to Present at Sidoti Virtual Investor Conference
Published: 2021-09-20 (Crawled : 22:00) - prnewswire.com
CODX | $1.155 0.43% 0.43% 10K

Health Technology

| -87.93% | O: 0.1% H: 3.35% C: 2.41%
diagnostics conference presentation diagnostic

Global Contract Development & Manufacturing Organization (CDMO) Industry Outlook to 2026, Featuring Profiles of Key Players Lonza Group, Catalent, Thermo Fisher, Jubilant Pharmova, and More
Published: 2021-09-20 (Crawled : 22:00) - prnewswire.com
CTLT | $56.03 -0.04% 0.0% 1.5M

Health Technology

| -58.8% | O: 0.82% H: 0.08% C: -0.74%
contract

Solid Biosciences to Provide Update on Long-Term Outcomes Data from Patients in the Ongoing IGNITE DMD Phase I/II Clinical Trial of SGT-001
Published: 2021-09-20 (Crawled : 22:00) - biospace.com/
SLDB | $9.08 0.44% 0.44% 300K

Health Technology

| 225.36% | O: -1.43% H: 0.36% C: -3.62%
ongoing trial dmd

Genmab and Seagen Announce FDA Accelerated Approval for TIVDAK™ (tisotumab vedotin-tftv) in Previously Treated Recurrent or Metastatic Cervical Cancer
Published: 2021-09-20 (Crawled : 22:00) - globenewswire.com
SGEN | $228.74 0.1% 20M

Health Technology

| 43.81% | O: 0.26% H: 7.15% C: 3.47%
GMAB | News | $28.54 -1.48% -1.51% 560K

Health Technology

| -33.24% | O: 3.52% H: 0.73% C: -0.06%
fda cancer approval

Natural Alternatives International, Inc. Announces 2021 Q4 and YTD Results
Published: 2021-09-20 (Crawled : 21:00) - prnewswire.com
NAII | $6.35 -2.31% -2.36% 11K

Health Technology

| -55.35% | O: -1.97% H: 6.75% C: 3.81%
results q4

PTC Therapeutics to Host Conference Call to Discuss Results of PTC518 Phase 1 Study for Huntington's Disease Program
Published: 2021-09-20 (Crawled : 21:00) - prnewswire.com
PTCT | News S | $25.38 -2.27% -2.32% 750K

Health Technology

| -37.55% | O: 0.26% H: 5.28% C: 4.48%
huntington disease phase 1 results conference phase 2 huntington’s disease

Life Sciences and Healthcare Industry Leaders Invest in Tact.ai to Deliver Next Generation Customer Engagement
Published: 2021-09-20 (Crawled : 21:00) - prnewswire.com
LLY | News | $745.69 1.96% -0.16% 2M

Health Technology

| 224.96% | O: 2.04% H: 0.72% C: -0.81%
life science liver

Aprea Therapeutics Presents Data From Phase 1/2 Trial of Eprenetapopt (APR-246) in Advanced Solid Tumors at ESMO Congress 2021
Published: 2021-09-20 (Crawled : 21:00) - globenewswire.com
APRE | $5.1201 6.3% 2.6K

Health Technology

| 10.72% | O: 1.86% H: 2.23% C: -5.47%
solid tumors phase 1 trial

Conformis, Inc. Provides Business Update
Published: 2021-09-20 (Crawled : 21:00) - globenewswire.com
CFMS | $2.26 0.44% 0

Health Technology

| 33.53% | O: -4.12% H: 1.84% C: -6.75%

Vaxcyte Appoints Annie Drapeau and Teri Loxam to Its Board of Directors
Published: 2021-09-20 (Crawled : 21:00) - globenewswire.com
IMAX | News | $17.44 1.69% 0.0% 920K

Consumer Services